-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PbDY3AfD5SdnMBCSW6ltGxJNlNwM3pn3sIwlq6srHalw3UGETYRy234uD2Rh1+E4 +Zh2o022BbnMiDp8RUBjEQ== 0000950136-07-004002.txt : 20070606 0000950136-07-004002.hdr.sgml : 20070606 20070606141752 ACCESSION NUMBER: 0000950136-07-004002 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20070606 DATE AS OF CHANGE: 20070606 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLIED HEALTHCARE INTERNATIONAL INC CENTRAL INDEX KEY: 0000890634 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 133098275 STATE OF INCORPORATION: NY FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45967 FILM NUMBER: 07903623 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127500064 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TRANSWORLD HEALTHCARE INC DATE OF NAME CHANGE: 19970610 FORMER COMPANY: FORMER CONFORMED NAME: TRANSWORLD HOME HEALTHCARE INC DATE OF NAME CHANGE: 19940728 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AITKEN TIMOTHY M CENTRAL INDEX KEY: 0001172489 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: C/O TRANSWORLD HEALTHCARE INC STREET 2: 555 MADISON AVE 30TH FL CITY: NEW YORK STATE: NY ZIP: 10022 SC 13D/A 1 file1.htm SCHEDULE 13D/A

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 28549

SCHEDULE 13D

INFORMATION TO BE IN INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT
TO RULE 13d-2(a)

(Amendment No. 6)

Allied Healthcare International Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

01923A 10 9

(CUSIP Number)

Timothy M. Aitken
Chairman of the Board and Chief Executive Officer
Allied Healthcare International Inc.
245 Park Avenue
New York, New York 10167

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

January 16, 2007

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. [ ]

SCHEDULE 13D

CUSIP No. 01923A 10 9

Page 2 of 4 Pages



1			NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Timothy M. Aitken
2			CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b)
3			SEC USE ONLY
4			SOURCE OF FUNDS
5			CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6			CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom
			NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSONAL WITH			7			SOLE VOTING POWER 1,898,853
						8			SHARED VOTING POWER 0
						9			SOLE DISPOSITIVE POWER 1,898,853
						10			SHARED DISPOSITIVE POWER
11			AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,898,853
12			CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13			PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.1%
14			TYPE OF REPORTING PERSON IN

1

This Amendment No. 6 amends Items 3 and 5 of the Schedule 13D filed by Timothy M. Aitken with the Securities and Exchange Commission on May 1, 2002, as amended by Amendment No. 1 thereto filed on August 12, 2002, Amendment No. 2 thereto filed on December 24, 2002, Amendment No. 3 thereto filed on January 15, 2004, Amendment No. 4 thereto filed on July 7, 2004, and Amendment 5 thereto filed on November 14, 2006 relating to the Common Stock, par value $0.01 per share (the ‘‘Common Stock’’), of Allied Healthcare International Inc. (the ‘‘Company’’).

Item 3. Source and Amount of Funds or Other Consideration.

Item 3(i) is amended by deleting therefrom the reference to options to purchase 500,000 shares of Common Stock that were granted to Mr. Aitken on January 15, 1997. Such options expired without having been exercised on January 16, 2007. As a result of the deletion of the reference to such options, Item 3(i) is amended to reflect the fact that Mr. Aitken has been granted 1,124,000 options to purchase shares of Common Stock, and that he currently holds options to purchase 1,118,280 shares of Common Stock, all of which are exercisable within 60 days of the date of this Amendment No. 6.

Item 5. Interest in Securities of the Issuer.

Item 5 is amended and restated to read as follows:

(a) As of June 1, 2007, there were 44,957,492 shares of Common Stock outstanding. The percentages reported in this statement have been rounded to the nearest one-tenth of a percent.

Mr. Aitken beneficially owns 1,898,853 shares of Common Stock, or 4.1%, of the outstanding shares of Common Stock, through (i) his beneficial ownership of 682,007 shares of Common Stock; (ii) his beneficial ownership of 98,566 shares of Common Stock held by Aitken (English) Company Limited, an affiliate of Mr. Aitken; and (iii) options to purchase an aggregate of 1,118,280 shares of Common Stock which are exercisable within 60 days of the date of this Amendment No. 6 to Schedule 13D.

(b) Mr. Aitken has, or will have upon the exercise of stock options, the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of all shares of Common Stock identified in paragraph (a) above.

(c) During the last 60 days, Mr. Aitken has not effected any transactions in the Common Stock.

(d) No person other than Mr. Aitken has the right to receive or the power to direct the receipt of the dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by Mr. Aitken.

(e) On January 16, 2007, as a result of the expiration of the exercise period of options to purchase 500,000 shares of Common Stock, Mr. Aitken ceased to be the beneficial owner of more than five percent of the shares of Common Stock.

2

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

/s/ Marvet Abbassi
Attorney-in-fact for Timothy M. Aitken

Date: June 5, 2007

3

GRAPHIC 2 ebox.gif begin 644 ebox.gif M1TE&.#EA"@`*`(```````/___R'Y!```````+``````*``H```(1A(\0RVO= - -'G1J!CDQU+'FE!0`.S\_ ` end GRAPHIC 3 spacer.gif begin 644 spacer.gif K1TE&.#EA`0`!`(```````````"'Y!`$`````+``````!``$```("1`$`.S\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----